| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 04/21/2005 | US20050085484 Anticancer agents, particluarly mammary glands, rectums; endometriosis; |
| 04/21/2005 | US20050085483 Obesity, type II diabetes; such as 6-(4-Chlorobenzyl)-1-(2,4-dichlorobenzenesulfonyl)-8-isopropylhexahydropyrazino[1,2-a]pyrimidine-4,7-dione |
| 04/21/2005 | US20050085476 Polymerase inhibitors; antiischemic agents; brain disorders; cardiovascular disorders; antiinflammatory agents; antiarthritic agents; neurodegenerative agents; Alzheimer's disease; muscular disorders; antidiabetic agents; kidney disorders; viricides; anticancer agents; immunosuppressants |
| 04/21/2005 | US20050085474 difluoroamine compounds |
| 04/21/2005 | US20050085472 Pyrazolo pyrimidine derivatives and methods of use thereof |
| 04/21/2005 | US20050085460 useful as therapeutics in treatment of cancers and the amelioration of the effects of stroke, head trauma, and neurodegenerative disease |
| 04/21/2005 | US20050085414 Novel medical use for tachykinin antagonists |
| 04/21/2005 | US20050085410 Artificial oxygen carrier and production method thereof |
| 04/21/2005 | US20050081748 Phthalocyanine dye in inks, use in an ink-jet printer; printer cartridges; paper printed with ink; light and ozone-fastness, solubility, storage stability |
| 04/21/2005 | CA2540249A1 Certain substituted spirocyclic lactams and use thereof as pharmaceuticals |
| 04/20/2005 | EP1523778A2 Heteroatom-containing diamondoid transistors |
| 04/20/2005 | EP1523528A1 Polymerisable diketopyrrolopyrroles, use of such compounds in colour filters and polymers prepared from these compounds |
| 04/20/2005 | EP1523527A1 Fibre-reactive azo dyes, their preparation and their use |
| 04/20/2005 | EP1523485A1 3-furanyl analogs of toxoflavine as kinase inhibitors |
| 04/20/2005 | EP1523484A2 3-phenyl analogs of toxoflavine as kinase inhibitors |
| 04/20/2005 | EP1523483A2 Amino-bicyclic pyrazinones and pyridinones as coagulation serine protease inhibitors |
| 04/20/2005 | EP1523314A2 Pyrazolopyrimidines as protein kinase inhibitors |
| 04/20/2005 | EP1283839B1 Adenosine a2a receptor antagonists |
| 04/20/2005 | EP1196417B1 1,2,3,4,5,6-HEXAHYDROAZEPINO 4,5-b]INDOLES CONTAINING ARYLSULFONES AT THE 9-POSITION |
| 04/20/2005 | EP1152751B1 Desoxypeganine transdermal therapeutic system |
| 04/20/2005 | CN1608069A Selective androgen receptor modulators and methods for their identification, design and use |
| 04/20/2005 | CN1608068A Bridged bicyclic amino acid-derived [1, 4]benzodiazepine vasopressin receptor antagonists |
| 04/20/2005 | CN1608067A Pyrrolopyrimidines as phosphodiesterase vii inhibitors |
| 04/20/2005 | CN1197865C Method of selectively synthesizing triethylene diamine |
| 04/20/2005 | CN1197864C Process for preparation of pyrazolo pyridazine derivatives |
| 04/20/2005 | CN1197860C FAB I inhibitors |
| 04/19/2005 | US6881842 Chemical intermediate for making acetylcholinesterase enzyme inhibitors 8-(3-(1-((3-fluorophenyl)methyl)-4-piperidinyl)-1-oxopropyl)-1,2,5,6 -tetrahydro-4H-pyrrolo (3,2,1-ij)quinoline-4-one |
| 04/19/2005 | US6881749 Pyranoindazoles and their use for the treatment of glaucoma |
| 04/14/2005 | WO2005033930A2 Process for upgrading naphtha |
| 04/14/2005 | WO2005033111A1 Dihydroporphine derivatives, processes for their preparation,and pharmaceutical compositions containing them |
| 04/14/2005 | WO2005033110A1 Processes for producing polysubstituted phythalocyanines |
| 04/14/2005 | WO2005033109A1 Triazinoindolamine compound |
| 04/14/2005 | WO2005033108A1 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones |
| 04/14/2005 | WO2005033102A2 Thiophene-based compounds exhibiting atp-utilizing enzyme inhibitory activity, and compositions, and uses thereof |
| 04/14/2005 | WO2005033048A2 Wnt pathway antagonists |
| 04/14/2005 | WO2005032594A2 Alkylators linked to polyamides as dna binding agents |
| 04/14/2005 | WO2005032481A2 Quinazoline derivatives as medicaments |
| 04/14/2005 | WO2005032256A1 Fungicidal mixtures |
| 04/14/2005 | WO2005013892A9 Hydrolytically-resistant boron-containing therapeutics and methods of use |
| 04/14/2005 | WO2005012306A3 Imidazo-pyrimidines and triazolo-pyrimidines: benzodiazepine receptor ligands |
| 04/14/2005 | WO2005007657A3 Use of dbn and dbu salts as ionic liquids |
| 04/14/2005 | WO2005007099A3 Pkb inhibitors as anti-tumor agents |
| 04/14/2005 | WO2005002514A3 Compounds having inhibitibe activity of phosphatidylinositol 3-kinase and methods of use thereof |
| 04/14/2005 | WO2004112699A3 Mitotic kinesin inhibitors |
| 04/14/2005 | WO2004105700A3 Compounds, methods and pharmaceutical compositions for inhibiting parp |
| 04/14/2005 | US20050080260 Preparation of prodrugs for selective drug delivery |
| 04/14/2005 | US20050080141 Amino diols useful in the treatment of alzheimer's disease |
| 04/14/2005 | US20050080119 Diaminopropionic acid derivatives |
| 04/14/2005 | US20050080097 5-[1-(hydroxymethyl)propyl]amino-7-benzylamino-3-isopropyl(methyl, ethyl)pyrazolo[4,3-d]pyrimidine for inhibiting cell proliferation, cancer, or psoriasis, rheumatoid arthritis, lupus, diabetes, multiple sclerosis, restenosis, polycystic kidney disease, graft rejection, and neurodegerative diseases |
| 04/14/2005 | US20050080095 Novel amides useful for treating pain |
| 04/14/2005 | US20050080086 Pharmaceutical uses and synthesis of diketopiperazines |
| 04/14/2005 | US20050080074 Such as (+-)-1,3,4,10b-tetrahydro-7-trifluoromethoxy-pyrazino[2,1-a]isoindol-6(2H)-one for treatment of metabolic disorders, central nervous system disorders, and gastrointestinal disorders |
| 04/14/2005 | US20050080068 using bis (phthalhydrazides) as glycoluril surrogates to control the size, shape and pattern of functional groups in curcubit forming reactions; form host-guest complexes |
| 04/14/2005 | US20050079979 Substituted benzoylisoxazoles and the use thereof as herbicides |
| 04/14/2005 | DE10337496A1 4-Biphenylsubstituierte-4-substituierte-pyrazolidin-3,5-dione 4-biphenyl-4-substituted-pyrazolidine-3,5-diones |
| 04/14/2005 | CA2582437A1 Dihydroporphine derivatives, processes for their preparation, and pharmaceutical compositions containing them |
| 04/14/2005 | CA2540517A1 Process for upgrading naphtha |
| 04/14/2005 | CA2539580A1 Fungicidal mixtures |
| 04/13/2005 | EP1521828A2 Production of polyketides |
| 04/13/2005 | EP1521802A1 High-molecular-weight polymeric material comprising diketopyrrolopyrrole pigments |
| 04/13/2005 | EP1521756A1 Hetero-cyclicaly substituted imidazotriazines |
| 04/13/2005 | EP1521755A1 Novel diketopyrrolopyrrole pigments |
| 04/13/2005 | EP1521747A2 Receptor-type kinase modulators and methods of use |
| 04/13/2005 | EP1521583A1 7,8,9,10-tetrahydro-6h-azepino, 6,7,8,9-tetrahydro-pyrido and 2,3-dihydro-2h-pyrrolo (2,1-b)-quinazolinone derivatives |
| 04/13/2005 | EP1366050B1 Condensed pyrazindione derivatives as pde inhibitors |
| 04/13/2005 | EP1105728B1 Modulating multiple lineage kinase proteins |
| 04/13/2005 | CN1606557A Deuterated pyrazolopyrimidinones and drugs containing said compounds |
| 04/13/2005 | CN1606555A Imidazoquinoline derivatives |
| 04/13/2005 | CN1606553A Oxytocin agonistenoxytocin agonisten |
| 04/13/2005 | CN1606545A Pyrrolidine and piperidine derivates as nk1 antagonists |
| 04/13/2005 | CN1606444A Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 04/13/2005 | CN1197067C Optical recording media and porphinoid compound |
| 04/13/2005 | CN1196704C Process for preparing inhibitors of nucleoside metabolism |
| 04/13/2005 | CN1196703C Pyrazolobenzodiazepines as CDK2 inhibitors |
| 04/13/2005 | CN1196487C 单位剂量形式 The unit dosage form |
| 04/12/2005 | US6878823 Substituted and unsubstitued 9-arylsulfone- 1,2,3,4,5,6-hexahydroazepino (4,5-b) indoles are useful in treatment of depression, obesity and other central nervous system disorders |
| 04/12/2005 | US6878821 Modifying chemoselectivity during oxidation of nitrogen compounds |
| 04/12/2005 | US6878738 E.g., 2-(2-(4-Chlorophenyl)-6-hydroxymethyl-6-methyl-1-phenyl-6,7- dihydro-5H-pyrrolizin-3-yl)acetic acid; inhibition of 5-lipoxygenase and cyclooxygenase |
| 04/12/2005 | US6878716 Compounds specific to adenosine A1 receptor and uses thereof |
| 04/12/2005 | US6878715 Xanthine derivatives such as 1-(5-N,N-dimethylaminohexyl)-3,7-dimethylxanthine |
| 04/12/2005 | US6878708 Imidazotriazinones and the use thereof |
| 04/12/2005 | US6878704 Heterocyclic mutilin esters and their use as antibacterials |
| 04/12/2005 | US6878701 Potassium channel blocking agents |
| 04/12/2005 | CA2178783C Zilpaterol chlorhydrate with a specific cristalline structure, process for preparing the same and intermediates used therefor |
| 04/07/2005 | WO2005030796A1 Macrocyclic inhibitors of hepatitis c virus ns3 serine protease |
| 04/07/2005 | WO2005030777A1 Non-amide nonanes |
| 04/07/2005 | WO2005030776A1 Pyrazolopyrrole derivatives as protein kinase inhibitors |
| 04/07/2005 | WO2005030775A1 6-[(substituted)phenyl]triazolopyrimidines as anticancer agents |
| 04/07/2005 | WO2005030773A1 Novel pyrazolopyrimidine derivatives |
| 04/07/2005 | WO2005030711A2 Bridged macrocyclic module compositions |
| 04/07/2005 | WO2005030705A1 Inhibitors of histone deacetylase |
| 04/07/2005 | WO2005030704A1 Inhibitors of histone deacetylase |
| 04/07/2005 | WO2005030218A1 6-aryl-7-halo-imidazo[1,2-a]pyrimidines as anticancer agent |
| 04/07/2005 | WO2005030217A1 Quinazoline potassium channel inhibitors |
| 04/07/2005 | WO2005030213A1 1,1,1-trifluoro-4-phenyl-4-methyl-2-(1h-pyrrolo |
| 04/07/2005 | WO2005030144A2 Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders |
| 04/07/2005 | WO2005030131A2 Bis-quinazoline compounds for the treatment of bacterial infections |
| 04/07/2005 | WO2005016873A3 4-biphenylsubstituted pyrazolidin-3,5-dione derivatives |
| 04/07/2005 | WO2005012305A3 Tricyclic parp inhibitors |
| 04/07/2005 | WO2004112719A3 Chemical compounds |